|
KIAA1826 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.006200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.956200E-01 |
| Normal-vs-Stage2 |
4.365400E-01 |
| Normal-vs-Stage3 |
2.198000E-02 |
| Normal-vs-Stage4 |
6.613500E-02 |
| Stage1-vs-Stage2 |
2.709600E-01 |
| Stage1-vs-Stage3 |
9.721300E-03 |
| Stage1-vs-Stage4 |
4.919700E-02 |
| Stage2-vs-Stage3 |
2.333800E-02 |
| Stage2-vs-Stage4 |
5.213800E-02 |
| Stage3-vs-Stage4 |
8.668200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.910200E-01 |
| Normal-vs-AfricanAmerican |
5.612400E-01 |
| Normal-vs-Asian |
4.797600E-01 |
| Caucasian-vs-AfricanAmerican |
8.400200E-01 |
| Caucasian-vs-Asian |
4.605400E-01 |
| AfricanAmerican-vs-Asian |
5.253600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.126200E-01 |
| Normal-vs-Female |
5.616800E-01 |
| Male-vs-Female |
1.353580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.714250E-01 |
| Normal-vs-Extreme_Weight |
2.179800E-01 |
| Normal-vs-Obese |
9.764000E-01 |
| Normal-vs-Extreme_Obese |
9.174000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.997600E-01 |
| Normal_Weight-vs-Obese |
2.477400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.820800E-01 |
| Extreme_Weight-vs-Obese |
3.085200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.974200E-01 |
| Obese-vs-Extreme_Obese |
9.628400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.728990E-01 |
| Normal-vs-Age(41-60Yrs) |
4.970000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.833200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.780700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.257800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.239800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.110600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.360100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.987730E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.174300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.929400E-01 |
| Normal-VS-Type2 PRCC |
1.851390E-01 |
| Normal-VS-KIRP CIMP |
6.49802434082858E-12 |
| Normal-VS-Unclassified PRCC |
2.212200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.328630E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.44419998182599E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
2.021400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.55089965711863E-10 |
| Type2 PRCC-VS-Unclassified PRCC |
5.107800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.27910024186428E-10 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.389400E-01 |
| Normal-vs-N1 |
2.544600E-03 |
| Normal-vs-N2 |
3.397400E-04 |
| N0-vs-N1 |
2.690300E-02 |
| N0-vs-N2 |
3.571800E-02 |
| N1-vs-N2 |
3.379000E-01 |
|
|
